Testing a new 3D method to choose treatments for triple-negative breast cancer
Validation of a novel 3D culture platform for TNBC treatment selection
This study is testing a new way to grow tumor samples in 3D, called E-slices, to help doctors figure out the best treatment for people with triple-negative breast cancer, so they can better predict how well new chemoimmunotherapy options will work for each patient.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10911923 on NIH RePORTER |
What this research studies
This research aims to validate a new 3D tumor tissue culture method called E-slices, which could help personalize treatment for patients with triple-negative breast cancer (TNBC). By using this innovative approach, the researchers hope to predict how individual patients will respond to recently approved chemoimmunotherapy treatments. The study is a collaboration between the Houston Methodist Research Institute and MD Anderson Cancer Center, focusing on improving the accuracy of cancer diagnostics. This method seeks to overcome the limitations of current genomic-based assays that only benefit a small percentage of patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with triple-negative breast cancer who are seeking personalized treatment options.
Not a fit: Patients with other types of breast cancer or those not diagnosed with breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with triple-negative breast cancer.
How similar studies have performed: While functional assays like organoids and PDX models have been developed, this specific 3D culture method is a novel approach that has not been widely tested in clinical settings.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Yun, Kyuson — Methodist Hospital Research Institute
- Study coordinator: Yun, Kyuson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.